AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/179
INFLUENCE OF ALLOSTERIC MODULATORS OF MUSCARINIC RECEPTORS ON THE DISSOCIATION CHARACTERISTICS OF RADIOLIGANDS OF A(1)-ADENOSINE-ADRENERGIC, ALPHA(1)-ADRENERGIC AND BETA-ADRENERGIC RECEPTORS
Authors: PFAFFENDORF M BATINK HD TRANKLE C MOHR K VANZWIETEN PA
Citation: M. Pfaffendorf et al., INFLUENCE OF ALLOSTERIC MODULATORS OF MUSCARINIC RECEPTORS ON THE DISSOCIATION CHARACTERISTICS OF RADIOLIGANDS OF A(1)-ADENOSINE-ADRENERGIC, ALPHA(1)-ADRENERGIC AND BETA-ADRENERGIC RECEPTORS, Life sciences, 60(13-14), 1997, pp. 20-20
ROLE OF CEREBRAL ATROPHY IN THE MEASUREMENT OF MUSCARINIC RECEPTOR DENSITY IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: DUBOIS EA CLAUS J BOOIJ J HABRAKEN J DEMUNCK J VERBEETEN BWJM WALSTRA GJM VANROYEN EA PFAFFENDORF M VANZWIETEN PA
Citation: Ea. Dubois et al., ROLE OF CEREBRAL ATROPHY IN THE MEASUREMENT OF MUSCARINIC RECEPTOR DENSITY IN PATIENTS WITH ALZHEIMERS-DISEASE, Life sciences, 60(13-14), 1997, pp. 86-86
RECENT CHANGES IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE - SATELLITE SYMPOSIUM AT THE JOINT 12TH WORLD CONGRESS OF CARDIOLOGY AND 16TH CONGRESS OF THE EUROPEAN-SOCIETY-OF-CARDIOLOGY - INTRODUCTION
Authors: VANZWIETEN PA
Citation: Pa. Vanzwieten, RECENT CHANGES IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE - SATELLITE SYMPOSIUM AT THE JOINT 12TH WORLD CONGRESS OF CARDIOLOGY AND 16TH CONGRESS OF THE EUROPEAN-SOCIETY-OF-CARDIOLOGY - INTRODUCTION, Cardiology, 88, 1997, pp. 1-1
THE INTERACTION BETWEEN METHYLENE-BLUE AND THE CHOLINERGIC SYSTEM
Authors: PFAFFENDORF M BRUNING TA BATINK HD VANZWIETEN PA
Citation: M. Pfaffendorf et al., THE INTERACTION BETWEEN METHYLENE-BLUE AND THE CHOLINERGIC SYSTEM, British Journal of Pharmacology, 122(1), 1997, pp. 95-98
ALLOSTERIC MODULATION BY ALCURONIUM, GALLAMINE AND W84 IS NOT A COMMON FEATURE OF G-PROTEIN COUPLED RECEPTORS BUT SPECIFIC FOR CARDIAC MUSCARINIC RECEPTORS
Authors: PFAFFENDORF M BATINK HD TRANKLE C MOHR K VANZWIETEN PA
Citation: M. Pfaffendorf et al., ALLOSTERIC MODULATION BY ALCURONIUM, GALLAMINE AND W84 IS NOT A COMMON FEATURE OF G-PROTEIN COUPLED RECEPTORS BUT SPECIFIC FOR CARDIAC MUSCARINIC RECEPTORS, British Journal of Pharmacology, 120, 1997, pp. 103-103
HYPERTHYROID-INDUCED AND HYPOTHYROID-INDUCED MODULATION OF ALPHA(1)-ADRENOCEPTORS AND THEIR SUBTYPES IN RAT LEFT-VENTRICLE
Authors: ZWAVELING J BATINK HD PRINS EAW PFAFFENDORF M VANZWIETEN PA
Citation: J. Zwaveling et al., HYPERTHYROID-INDUCED AND HYPOTHYROID-INDUCED MODULATION OF ALPHA(1)-ADRENOCEPTORS AND THEIR SUBTYPES IN RAT LEFT-VENTRICLE, British Journal of Pharmacology, 120, 1997, pp. 105-105
CONTRACTILE EFFECT OF ANGIOTENSIN PEPTIDES IN HUMAN ISOLATED SAPHENOUS-VEIN
Authors: LI Q FEENSTRA M PFAFFENDORF M EIJSMAN L VANZWIETEN PA
Citation: Q. Li et al., CONTRACTILE EFFECT OF ANGIOTENSIN PEPTIDES IN HUMAN ISOLATED SAPHENOUS-VEIN, British Journal of Pharmacology, 120, 1997, pp. 113-113
FUNCTIONAL-RESPONSES TO VARIOUS DRUGS IN RAT CAROTID ARTERIES WITH INTIMAL HYPERPLASIA
Authors: HEIJENBROK FJ PFAFFENDORF M VANZWIETEN PA
Citation: Fj. Heijenbrok et al., FUNCTIONAL-RESPONSES TO VARIOUS DRUGS IN RAT CAROTID ARTERIES WITH INTIMAL HYPERPLASIA, British Journal of Pharmacology, 120, 1997, pp. 176-176
INFLUENCE OF OXIDATIVE STRESS ON BETA-ADRENOCEPTOR-MEDIATED INOTROPICEFFECTS
Authors: PETERS SLM PFAFFENDORF M VANZWIETEN PA
Citation: Slm. Peters et al., INFLUENCE OF OXIDATIVE STRESS ON BETA-ADRENOCEPTOR-MEDIATED INOTROPICEFFECTS, British Journal of Pharmacology, 120, 1997, pp. 177-177
PHARMACOLOGICAL CHARACTERIZATION IN-VITRO AND IN-VIVO OF IODINE 123-LABELED DERIVATIVES OF THE BETA-ADRENOCEPTOR ANTAGONIST CGP12177, DESIGNED FOR THE IMAGING OF CARDIAC BETA-RECEPTORS
Authors: DUBOIS EA SOMSEN GA VANDENBOS JC JANSSEN AGM BOER GJ BATINK HD VANROYEN EA PFAFFENDORF M VANZWIETEN PA
Citation: Ea. Dubois et al., PHARMACOLOGICAL CHARACTERIZATION IN-VITRO AND IN-VIVO OF IODINE 123-LABELED DERIVATIVES OF THE BETA-ADRENOCEPTOR ANTAGONIST CGP12177, DESIGNED FOR THE IMAGING OF CARDIAC BETA-RECEPTORS, Journal of nuclear cardiology, 3(3), 1996, pp. 242-252
NEW CENTRAL MEDIATORS AS TARGETS OF CENTRALLY ACTING ANTIHYPERTENSIVEDRUGS
Authors: VANZWIETEN PA
Citation: Pa. Vanzwieten, NEW CENTRAL MEDIATORS AS TARGETS OF CENTRALLY ACTING ANTIHYPERTENSIVEDRUGS, Clinical and experimental hypertension, 18(3-4), 1996, pp. 291-303
EFFECTS OF DOBUTAMINE AND ENOXIMONE ON TRANSMITRAL AND PULMONARY VENOUS FLOW CHARACTERISTICS IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER CORONARY-ARTERY BYPASS-GRAFTING
Authors: VROOM MB VANWEZEL HB VANDERBRINK RBA VANDERLEE R EIJSMAN L VISSER CA VANZWIETEN PA
Citation: Mb. Vroom et al., EFFECTS OF DOBUTAMINE AND ENOXIMONE ON TRANSMITRAL AND PULMONARY VENOUS FLOW CHARACTERISTICS IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER CORONARY-ARTERY BYPASS-GRAFTING, Journal of cardiothoracic and vascular anesthesia, 10(6), 1996, pp. 756-763
HYPERTENSIVE DIABETIC RATS IN PHARMACOLOGICAL STUDIES
Authors: VANZWIETEN PA KAM KL PIJL AJ HENDRIKS MGC BEENEN OHM PFAFFENDORF M
Citation: Pa. Vanzwieten et al., HYPERTENSIVE DIABETIC RATS IN PHARMACOLOGICAL STUDIES, Pharmacological research, 33(2), 1996, pp. 95-105
MODULATION OF SYMPATHETIC OUTFLOW BY CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS
Authors: VANZWIETEN PA
Citation: Pa. Vanzwieten, MODULATION OF SYMPATHETIC OUTFLOW BY CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS, Cardiovascular drugs and therapy, 10, 1996, pp. 283-289
PHARMACODYNAMIC BEHAVIOR OF ISOLATED RESISTANCE VESSELS OBTAINED FROMHYPERTENSIVE-DIABETIC RATS
Authors: KAM KL PFAFFENDORF M VANZWIETEN PA
Citation: Kl. Kam et al., PHARMACODYNAMIC BEHAVIOR OF ISOLATED RESISTANCE VESSELS OBTAINED FROMHYPERTENSIVE-DIABETIC RATS, Fundamental and clinical pharmacology, 10(4), 1996, pp. 329-336
CARDIAC I-123 METAIODOBENZYLGUANIDINE UPTAKE IN ANIMALS WITH DIABETES-MELLITUS AND OR HYPERTENSION/
Authors: DUBOIS EA KAM KL SOMSEN GA BOER GJ DEBRUIN K BATINK HD PFAFFENDORF M VANROYEN EA VANZWIETEN PA
Citation: Ea. Dubois et al., CARDIAC I-123 METAIODOBENZYLGUANIDINE UPTAKE IN ANIMALS WITH DIABETES-MELLITUS AND OR HYPERTENSION/, European journal of nuclear medicine, 23(8), 1996, pp. 901-908
VASCULAR RESPONSIVENESS IN ISOLATED-PERFUSED KIDNEYS OF DIABETIC HYPERTENSIVE RATS
Authors: BEENEN OHM MATHY MJ PFAFFENDORF M VANZWIETEN PA
Citation: Ohm. Beenen et al., VASCULAR RESPONSIVENESS IN ISOLATED-PERFUSED KIDNEYS OF DIABETIC HYPERTENSIVE RATS, Journal of hypertension, 14(9), 1996, pp. 1125-1130
INFLUENCE OF NIFEDIPINE ON PRESSOR-RESPONSES INDUCED BY DIFFERENT ALPHA-ADRENOCEPTOR AGONISTS AND ANGIOTENSIN-II IN PITHED DIABETIC HYPERTENSIVE RATS
Authors: BEENEN OHM MATHY MJ PFAFFENDORF M VANZWIETEN PA
Citation: Ohm. Beenen et al., INFLUENCE OF NIFEDIPINE ON PRESSOR-RESPONSES INDUCED BY DIFFERENT ALPHA-ADRENOCEPTOR AGONISTS AND ANGIOTENSIN-II IN PITHED DIABETIC HYPERTENSIVE RATS, Journal of hypertension, 14(7), 1996, pp. 847-853
CLINICAL-PHARMACOLOGY OF CALCIUM-ANTAGONISTS AS ANTIHYPERTENSIVE AND ANTIANGINAL DRUGS
Authors: VANZWIETEN PA
Citation: Pa. Vanzwieten, CLINICAL-PHARMACOLOGY OF CALCIUM-ANTAGONISTS AS ANTIHYPERTENSIVE AND ANTIANGINAL DRUGS, Journal of hypertension, 14, 1996, pp. 3-9
SAFETY OF THE CALCIUM-ANTAGONIST LACIDIPINE EVALUATED FROM A PHASE ILL-IV TRIAL DATABASE - DISCUSSION
Authors: VANZWIETEN PA LINDHOLM LH DEVEREUX RB ZANCHETTI A MENARD J SEVER PS
Citation: Pa. Vanzwieten et al., SAFETY OF THE CALCIUM-ANTAGONIST LACIDIPINE EVALUATED FROM A PHASE ILL-IV TRIAL DATABASE - DISCUSSION, Journal of hypertension, 14, 1996, pp. 20-20
BLOOD-PRESSURE-LOWERING FOR THE SECONDARY PREVENTION OF STROKE - RATIONALE AND DESIGN FOR PROGRESS - DISCUSSION
Authors: VANZWIETEN PA MACMAHON S DEVEREUX RB SALVETTI A
Citation: Pa. Vanzwieten et al., BLOOD-PRESSURE-LOWERING FOR THE SECONDARY PREVENTION OF STROKE - RATIONALE AND DESIGN FOR PROGRESS - DISCUSSION, Journal of hypertension, 14, 1996, pp. 45-46
COST-EFFECTIVENESS CALCULATIONS FROM TRIALS - DISCUSSION
Authors: VANZWIETEN PA AMBROSIONI E SEVER PS MACMAHON S FROHLICH ED KRAKOFF LR ZANCHETTI A SWALES JD HANSSON L MANCIA G MENARD J
Citation: Pa. Vanzwieten et al., COST-EFFECTIVENESS CALCULATIONS FROM TRIALS - DISCUSSION, Journal of hypertension, 14, 1996, pp. 52-54
DOES ANTIHYPERTENSIVE THERAPY PROTECT THE KIDNEY IN ESSENTIAL-HYPERTENSION - DISCUSSION
Authors: FROHLICH ED RODICIO JL HANSSON L VANZWIETEN PA SALVETTI A
Citation: Ed. Frohlich et al., DOES ANTIHYPERTENSIVE THERAPY PROTECT THE KIDNEY IN ESSENTIAL-HYPERTENSION - DISCUSSION, Journal of hypertension, 14, 1996, pp. 75-76
TRIALS INVESTIGATING THE ANTIATHEROSCLEROTIC EFFECTS OF ANTIHYPERTENSIVE DRUGS - DISCUSSION
Authors: DEVEREUX R ZANCHETTI A VANZWIETEN PA SALVETTI A RAHN KH HANSSON L SAFAR M FROHLICH ED
Citation: R. Devereux et al., TRIALS INVESTIGATING THE ANTIATHEROSCLEROTIC EFFECTS OF ANTIHYPERTENSIVE DRUGS - DISCUSSION, Journal of hypertension, 14, 1996, pp. 80-81
MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION AND DIABETES-MELLITUS - DISCUSSION
Authors: RODICIO JL PARVING HH RAHN KH HANSSON L MENARD J MANCIA G VANZWIETEN PA
Citation: Jl. Rodicio et al., MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION AND DIABETES-MELLITUS - DISCUSSION, Journal of hypertension, 14, 1996, pp. 93-94
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>